IMC Chicago’s Axcelis ACLS Stock Holding History

IMC Chicago’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,736	Closed	-$999K	–	6306
2026 Q1	$627K	Buy	+6,736	New	+$597K	﹤0.01%	3782
2025 Q2	–	Sell	-11,308	Closed	-$645K	–	3267
2025 Q1	$562K	Buy	+11,308	New	+$715K	﹤0.01%	2590

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

IMC Chicago's ACLS Position: Q2 2026 in Review

IMC Chicago sold out of Axcelis (ACLS) in Q2 2026, closing a stake of 6,736 shares — an estimated $999K sold.

IMC Chicago first reported a position in ACLS in Q1 2025 and held it in 2 quarters. The position peaked at $627K in Q1 2026. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

IMC Chicago reported no remaining Axcelis position as of Q2 2026 after selling out during the quarter.
IMC Chicago sold 6,736 Axcelis shares in Q2 2026, an estimated $999K.
IMC Chicago first reported a position in Axcelis in Q1 2025 and held it in 2 quarters.
IMC Chicago's Axcelis position peaked at $627K in Q1 2026.
441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.